Full-field optical coherence tomography for the diagnosis of giant cell arteritis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 17 05 2020
accepted: 13 08 2020
entrez: 1 9 2020
pubmed: 1 9 2020
medline: 2 10 2020
Statut: epublish

Résumé

Histopathological examination of temporal artery biopsy (TAB) remains the gold standard for the diagnosis of giant cell arteritis (GCA) but is associated with essential limitations that emphasize the need for an upgraded pathological process. This study pioneered the use of full-field optical coherence tomography (FF-OCT) for rapid and automated on-site pathological diagnosis of GCA. Sixteen TABs (12 negative and 4 positive for GCA) were selected according to major histopathological criteria of GCA following hematoxylin-eosin-saffron-staining for subsequent acquisition with FF-OCT to compare structural modifications of the artery cell wall and thickness of each tunica. Gabor filtering of FF-OCT images was then used to compute TAB orientation maps and validate a potential automated analysis of TAB sections. FF-OCT allowed both qualitative and quantitative visualization of the main structures of the temporal artery wall, from the internal elastic lamina to the vasa vasorum and red blood cells, unveiling a significant correlation with conventional histology. FF-OCT imaging of GCA TABs revealed destruction of the media with distinct remodeling of the whole arterial wall into a denser reticular fibrous neo-intima, which is distinctive of GCA pathogenesis and accessible through automated Gabor filtering. Rapid on-site FF-OCT TAB acquisition makes it possible to identify some characteristic pathological lesions of GCA within a few minutes, paving the way for potential machine intelligence-based or even non-invasive diagnosis of GCA.

Identifiants

pubmed: 32866179
doi: 10.1371/journal.pone.0234165
pii: PONE-D-20-14732
pmc: PMC7458309
doi:

Banques de données

ClinicalTrials.gov
['NCT02158208', 'NCT02857192']

Types de publication

Clinical Trial Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0234165

Déclaration de conflit d'intérêts

We declare the paid employment of LLTech SAS (E. B.) to provide additional FF-OCT images acquisition and analysis. Besides, the commercial affiliation with LLTech SAS does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Curr Eye Res. 2015 May;40(5):526-34
pubmed: 25251769
Rheumatology (Oxford). 2018 Feb 1;57(2):318-321
pubmed: 29112741
J Clin Pathol. 2000 Feb;53(2):137-9
pubmed: 10767830
J Biomed Opt. 2016 Feb;21(2):26005
pubmed: 26857471
Eye (Lond). 2017 Jan;31(1):157-160
pubmed: 27740619
Rev Med Interne. 2016 Mar;37(3):154-65
pubmed: 26833145
Presse Med. 2019 Sep;48(9):917-918
pubmed: 31564552
JAMA. 2016 Jun 14;315(22):2442-58
pubmed: 27299619
Nat Rev Rheumatol. 2017 Oct;13(10):578-592
pubmed: 28905861
Am J Ophthalmol. 1999 Aug;128(2):211-5
pubmed: 10458178
Anal Cell Pathol (Amst). 2012;35(2):85-91
pubmed: 22297471
Int J Health Care Qual Assur. 2013;26(6):559-63
pubmed: 24003755
J Biomed Opt. 2017 Feb 1;22(2):26004
pubmed: 28195601
J Autoimmun. 2014 Feb-Mar;48-49:73-5
pubmed: 24461386
Free Radic Biol Med. 2001 Nov 15;31(10):1254-62
pubmed: 11705704
N Engl J Med. 2014 Jul 3;371(1):50-7
pubmed: 24988557
Autoimmun Rev. 2019 Jan;18(1):56-61
pubmed: 30408588
Opt Lett. 2002 Apr 1;27(7):530-2
pubmed: 18007855
Dermatology. 2012;224(1):84-92
pubmed: 22487768
Biomed Opt Express. 2016 Mar 24;7(4):1511-24
pubmed: 27446672
Rheumatology (Oxford). 2018 Feb 1;57(2):227-235
pubmed: 28460064
Science. 1991 Nov 22;254(5035):1178-81
pubmed: 1957169
ANZ J Surg. 2018 Mar;88(3):191-195
pubmed: 27800647
Autoimmun Rev. 2017 Aug;16(8):833-844
pubmed: 28564617
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Ann R Coll Surg Engl. 2014 May;96(4):257-60
pubmed: 24780014
J Cancer Res Clin Oncol. 2018 Oct;144(10):1967-1990
pubmed: 29926160
Ann Rheum Dis. 2018 May;77(5):636-643
pubmed: 29358285
Nat Med. 1995 Sep;1(9):970-2
pubmed: 7585229

Auteurs

Thomas Maldiney (T)

Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.

Hélène Greigert (H)

Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.
University of Bourgogne-Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Dijon, Bourgogne-Franche-Comté, France.

Laurent Martin (L)

University of Bourgogne-Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Dijon, Bourgogne-Franche-Comté, France.
Department of Pathology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.

Emilie Benoit (E)

LLTech SAS, Paris, France.

Catherine Creuzot-Garcher (C)

Department of Ophthalmology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.

Pierre-Henry Gabrielle (PH)

Department of Ophthalmology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.

Jean-Marie Chassot (JM)

Institut Langevin, ESPCI Paris, CNRS, PSL University, Paris, France.

Claude Boccara (C)

LLTech SAS, Paris, France.
Institut Langevin, ESPCI Paris, CNRS, PSL University, Paris, France.

Daniel Balvay (D)

Université de Paris, PARCC, INSERM, Paris, France.

Bertrand Tavitian (B)

Université de Paris, PARCC, INSERM, Paris, France.
Radiology Department, Hôpital Européen Georges Pompidou, Université Paris Descartes Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Paris, France.

Olivier Clément (O)

Université de Paris, PARCC, INSERM, Paris, France.
Radiology Department, Hôpital Européen Georges Pompidou, Université Paris Descartes Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Paris, France.

Sylvain Audia (S)

Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.
University of Bourgogne-Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Dijon, Bourgogne-Franche-Comté, France.

Bernard Bonnotte (B)

Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.
University of Bourgogne-Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Dijon, Bourgogne-Franche-Comté, France.

Maxime Samson (M)

Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, Bourgogne-Franche-Comté, France.
University of Bourgogne-Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Dijon, Bourgogne-Franche-Comté, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH